|
|
cation homeostasis
|
GO:0055080 |
212 |
0.629
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.504
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.499
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.435
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.411
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.383
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.379
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.367
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.346
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.342
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.337
|
Human |
|
|
regulation of system process
|
GO:0044057 |
200 |
0.314
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.297
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.278
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.277
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.273
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.268
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.259
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.256
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.253
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.243
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.242
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.207
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.206
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.205
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.196
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.187
|
|
|
|
branching involved in salivary gland morphogenesis
|
GO:0060445 |
26 |
0.185
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.182
|
Mouse |
|
|
immune effector process
|
GO:0002252 |
321 |
0.176
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.173
|
Human |
|
|
cation transport
|
GO:0006812 |
399 |
0.166
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.163
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.160
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.158
|
Mouse |
|
|
urogenital system development
|
GO:0001655 |
261 |
0.153
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.149
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.149
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.149
|
Mouse |
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.148
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.148
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.146
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.146
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.145
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.142
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.139
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.138
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.137
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.137
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.136
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.135
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.134
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.128
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.128
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.127
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.127
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.126
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.125
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.125
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.125
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.124
|
Human |
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.124
|
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.122
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.120
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.118
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.118
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.118
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.118
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.117
|
Human |
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.116
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.114
|
Human |
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.114
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.114
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.114
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.114
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.113
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.113
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.113
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.113
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.110
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.110
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.110
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.110
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.108
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.108
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.107
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.106
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.102
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.102
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.102
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.101
|
|
|
|
sympathetic neuron projection extension
|
GO:0097490 |
4 |
0.101
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.101
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.100
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.099
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.099
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.099
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.099
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.097
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.097
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.097
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.097
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.094
|
Human |
|
|
neural tube formation
|
GO:0001841 |
108 |
0.094
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.094
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.093
|
Mouse |
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.093
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.093
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.092
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.092
|
Human |
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.092
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.090
|
Human |
|
|
learning or memory
|
GO:0007611 |
148 |
0.089
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.089
|
|
|
|
mesenchymal epithelial cell signaling involved in lung development
|
GO:0060496 |
1 |
0.089
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.088
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.088
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.088
|
|
|
|
positive regulation of camp mediated signaling
|
GO:0043950 |
3 |
0.088
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.087
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.087
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.087
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.086
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.086
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.085
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.085
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.085
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.085
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.084
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.084
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.084
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.084
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.084
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.083
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.083
|
Human |
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.083
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.083
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.082
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.082
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.082
|
|
|
|
neuron projection extension involved in neuron projection guidance
|
GO:1902284 |
14 |
0.082
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.082
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.082
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.082
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.082
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.082
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.081
|
Mouse |
|
|
cell growth
|
GO:0016049 |
130 |
0.081
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.081
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.081
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.081
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.080
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.079
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.079
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.078
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.078
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.077
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.076
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.076
|
|
|
|
alpha beta t cell differentiation involved in immune response
|
GO:0002293 |
30 |
0.076
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.075
|
|
|
|
ventral trunk neural crest cell migration
|
GO:0036486 |
4 |
0.075
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.075
|
Human |
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.075
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.074
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.074
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.073
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.073
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.073
|
Rat |
|
|
cognition
|
GO:0050890 |
149 |
0.073
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.072
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.072
|
Human |
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.072
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.072
|
Human |
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.072
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.071
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.071
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.070
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.070
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.070
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.069
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.068
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.068
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.068
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.067
|
Human |
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.066
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.065
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.065
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.064
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.064
|
|
|
|
establishment of neuroblast polarity
|
GO:0045200 |
1 |
0.064
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.063
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.063
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.063
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.063
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.063
|
Human |
|
|
tube formation
|
GO:0035148 |
140 |
0.063
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.063
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.062
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.062
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.062
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.062
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.061
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.061
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.061
|
Human |
|
|
sympathetic neuron projection guidance
|
GO:0097491 |
4 |
0.060
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.060
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.060
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.060
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.060
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.059
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.059
|
Human |
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.059
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.058
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.058
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.058
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.058
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.058
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.057
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.057
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.057
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.057
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.057
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.057
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.057
|
|
|
|
t helper cell differentiation
|
GO:0042093 |
28 |
0.057
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.057
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.057
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.056
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.056
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.056
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.056
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.056
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.056
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.056
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.055
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.055
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.055
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.055
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.055
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.055
|
|
|
|
regulation of axon guidance
|
GO:1902667 |
13 |
0.055
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.055
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.055
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.054
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.054
|
|
|
|
blood vessel remodeling
|
GO:0001974 |
33 |
0.054
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.054
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.054
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.053
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.053
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.053
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.053
|
|
|
|
cerebellum vasculature morphogenesis
|
GO:0061301 |
1 |
0.052
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.052
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.052
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.052
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.052
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.052
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.052
|
Human |
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.051
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.051
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.051
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.051
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.050
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.050
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.049
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.049
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.049
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.049
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.049
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.049
|
Rat |
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.049
|
Human |
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.049
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.049
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.049
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.049
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.048
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.048
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.048
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.048
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.048
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.048
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.048
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.047
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.047
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.047
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.047
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.047
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.047
|
|
|
|
cerebellum vasculature development
|
GO:0061300 |
1 |
0.047
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.047
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.047
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.047
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.046
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.046
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.046
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.046
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.046
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.046
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.046
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.046
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.046
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.045
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.045
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.045
|
|
|
|
axon extension involved in axon guidance
|
GO:0048846 |
14 |
0.045
|
|
|
|
gonadotrophin releasing hormone neuronal migration to the hypothalamus
|
GO:0021828 |
3 |
0.045
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.045
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.045
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.044
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.044
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.044
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.044
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.044
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.044
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.043
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.043
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.043
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.043
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.043
|
|
|
|
regulation of camp mediated signaling
|
GO:0043949 |
7 |
0.043
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.043
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.043
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.043
|
|
|
|
cellular response to prostaglandin d stimulus
|
GO:0071799 |
1 |
0.043
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.043
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.043
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.042
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.042
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.042
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.042
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.042
|
|
|
|
positive regulation of white fat cell proliferation
|
GO:0070352 |
1 |
0.042
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.042
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.042
|
|
|
|
cd4 positive alpha beta t cell differentiation involved in immune response
|
GO:0002294 |
28 |
0.041
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.041
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.041
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.041
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.041
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.041
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.041
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.041
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.041
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.041
|
Human |
|
|
activation of immune response
|
GO:0002253 |
138 |
0.040
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.040
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.040
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.040
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.040
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.040
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.040
|
Mouse |
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.040
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.040
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.040
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.040
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.039
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.039
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.039
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.039
|
|
|
|
syncytiotrophoblast cell differentiation involved in labyrinthine layer development
|
GO:0060715 |
2 |
0.039
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.039
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.038
|
|
|
|
activin receptor signaling pathway
|
GO:0032924 |
18 |
0.038
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.038
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.038
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.038
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.038
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.038
|
Rat |
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.038
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.038
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.038
|
|
|
|
male anatomical structure morphogenesis
|
GO:0090598 |
4 |
0.038
|
|
|
|
bronchiole development
|
GO:0060435 |
3 |
0.037
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.037
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.037
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.037
|
|
|
|
progesterone secretion
|
GO:0042701 |
1 |
0.037
|
|
|
|
female genitalia morphogenesis
|
GO:0048807 |
3 |
0.037
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.037
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.037
|
Human |
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.037
|
|
|
|
regulation of timing of cell differentiation
|
GO:0048505 |
11 |
0.036
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.036
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.036
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.036
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.036
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
4 |
0.036
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.036
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.036
|
Human |
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.036
|
Human |
|
|
regulation of high voltage gated calcium channel activity
|
GO:1901841 |
2 |
0.036
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.036
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.036
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.036
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.036
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.035
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.035
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.035
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.035
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.035
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.035
|
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.035
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.035
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.035
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.034
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.034
|
|
|
|
bronchiole morphogenesis
|
GO:0060436 |
1 |
0.034
|
|
|
|
semaphorin plexin signaling pathway
|
GO:0071526 |
21 |
0.034
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.034
|
|
|
|
submandibular salivary gland formation
|
GO:0060661 |
1 |
0.034
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.034
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.034
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.034
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.034
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.034
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.034
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.034
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.034
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.034
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.034
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.033
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.033
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.033
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.033
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.033
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.033
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.033
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.033
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.033
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.033
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.033
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.033
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.033
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.033
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.032
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.032
|
Mouse |
|
|
amino acid transport
|
GO:0006865 |
61 |
0.032
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.032
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.032
|
|
|
|
venous blood vessel development
|
GO:0060841 |
13 |
0.032
|
|
|
|
vascular endothelial growth factor receptor signaling pathway
|
GO:0048010 |
24 |
0.032
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.032
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.032
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.032
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.032
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.032
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.031
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.031
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.031
|
Human |
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.031
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.031
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.031
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.031
|
|
|
|
adenylate cyclase modulating g protein coupled receptor signaling pathway
|
GO:0007188 |
54 |
0.031
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.031
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.031
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.031
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.031
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.031
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.030
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.030
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.030
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.030
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.030
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.030
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.030
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.030
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.030
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.030
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.030
|
|
|
|
white fat cell proliferation
|
GO:0070343 |
2 |
0.030
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.030
|
|
|
|
male genitalia morphogenesis
|
GO:0048808 |
4 |
0.029
|
|
|
|
lung secretory cell differentiation
|
GO:0061140 |
13 |
0.029
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.029
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.029
|
|
|
|
general adaptation syndrome
|
GO:0051866 |
2 |
0.029
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.029
|
|
|
|
establishment or maintenance of neuroblast polarity
|
GO:0045196 |
1 |
0.029
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.029
|
Human Mouse |
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.029
|
|
|
|
semicircular canal fusion
|
GO:0060879 |
1 |
0.029
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.029
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.029
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.029
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.028
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.028
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.028
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.028
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.028
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.028
|
|
